George JN

No ORCID on file · 1 paper in corpus
guideline 2019
Blood advances ·doi:10.1182/bloodadvances.2019000966

BACKGROUND: Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE: These…